Endocrinology, Vol 133, 1230-1238, Copyright © 1993 by Endocrine Society

ARTICLES

Differential regulation of human progesterone receptor A and B form- mediated trans-activation by phosphorylation

SM Kazmi, V Visconti, RK Plante, A Ishaque and C Lau
Biological Research Department, R. W. Johnson Pharmaceutical Research Institute, Don Mills, Ontario, Canada.

Hormone-dependent phosphorylation of progesterone receptors (PRs) plays a functional role in their transcriptional activity. However, hormone- independent phosphorylation has also been shown to modulate the chicken PR-mediated trans-activation in the presence of phosphorylating agents. The present study was designed to investigate the effects of protein kinase A- and protein kinase C-mediated signal transduction pathways on the regulation of the activity of the two forms of human PR (hPRA and hPRB). Similar to chicken PR, hPR was activated by 8-bromo-cAMP (8-Br- cAMP) in the absence of ligand, whereas 8-Br-cAMP synergized with the progestin agonist R5020 to amplify hPRA- and hPRB-mediated reporter activity. Interestingly, the effect of 8-Br-cAMP was much more pronounced on hPRA-induced trans-activation than on hPRB. This differential regulation by 8-Br-cAMP could also be mimicked by okadaic acid. Both mouse mammary tumor virus-thymidine kinase-chloramphenicol acetyl transferase and progesterone response element-thymidine kinase- chloramphenicol acetyl transferase showed a similar response to 8-Br- cAMP in the presence of R5020. Protein kinase C, on the other hand, did not discriminate between hPRA- and hPRB-mediated trans-activation. Unlike 8-Br-cAMP, phorbol 12-myristate 13-acetate did not cause marked ligand-independent trans-activation through either of the two receptor forms. RU486, an antagonist of progestin, preferentially blocked R5020- induced trans-activation compared to R5020 + 8-Br-cAMP synergism. As expected, H-89, a specific inhibitor of protein kinase A was more effective in inhibiting ligand-independent activity. Western analysis of transfected receptors suggested that 8-Br-cAMP and 8-Br-cAMP + R5020 but not R5020 alone down-regulated the level of hPRB in COS-1 cells. Only marginal modulation of hPRA levels was observed with R5020 treatment in the presence and absence of 8-Br-cAMP. These data suggest that R5020 and 8-Br-cAMP mediate PR-dependent transactivation through distinct pathways, and that phosphorylation can differentially regulate the activity of hPRA and hPRB forms, an observation which may be important for selective target gene activation in vivo by progestins.

This article has been cited by other articles:

				S. Mani Progestin Receptor Subtypes in the Brain: The Known and the Unknown Endocrinology, June 1, 2008; 149(6): 2750 - 2756. [Abstract] [Full Text] [PDF]

				S. K. Mani, A. M. Reyna, J. Z. Chen, B. Mulac-Jericevic, and O. M. Conneely Differential Response of Progesterone Receptor Isoforms in Hormone-Dependent and -Independent Facilitation of Female Sexual Receptivity Mol. Endocrinol., June 1, 2006; 20(6): 1322 - 1332. [Abstract] [Full Text] [PDF]

				P A Mote, J F Johnston, T Manninen, P Tuohimaa, and C L Clarke Detection of progesterone receptor forms A and B by immunohistochemical analysis J. Clin. Pathol., August 1, 2001; 54(8): 624 - 630. [Abstract] [Full Text] [PDF]

				R. L. Arnett-Mansfield, A. deFazio, G. V. Wain, R. C. Jaworski, K. Byth, P. A. Mote, and C. L. Clarke Relative Expression of Progesterone Receptors A and B in Endometrioid Cancers of the Endometrium Cancer Res., June 1, 2001; 61(11): 4576 - 4582. [Abstract] [Full Text] [PDF]

				G. Giannoukos, D. Szapary, C. L. Smith, J. E. W. Meeker, and S. S. Simons Jr. New Antiprogestins with Partial Agonist Activity: Potential Selective Progesterone Receptor Modulators (SPRMs) and Probes for Receptor- and Coregulator-Induced Changes in Progesterone Receptor Induction Properties Mol. Endocrinol., February 1, 2001; 15(2): 255 - 270. [Abstract] [Full Text]

				B. G. Rowan, N. Garrison, N. L. Weigel, and B. W. O'Malley 8-Bromo-Cyclic AMP Induces Phosphorylation of Two Sites in SRC-1 That Facilitate Ligand-Independent Activation of the Chicken Progesterone Receptor and Are Critical for Functional Cooperation between SRC-1 and CREB Binding Protein Mol. Cell. Biol., December 1, 2000; 20(23): 8720 - 8730. [Abstract] [Full Text]

				P. E. Chappell, J. Lee, and J. E. Levine Stimulation of Gonadotropin-Releasing Hormone Surges by Estrogen. II. Role of Cyclic Adenosine 3',5'-Monophosphate Endocrinology, April 1, 2000; 141(4): 1486 - 1492. [Abstract] [Full Text] [PDF]

				E. M. McGowan and C. L. Clarke Effect of Overexpression of Progesterone Receptor A on Endogenous Progestin-Sensitive Endpoints in Breast Cancer Cells Mol. Endocrinol., October 1, 1999; 13(10): 1657 - 1671. [Abstract] [Full Text]

				J. J. Brosens, N. Hayashi, and J. O. White Progesterone Receptor Regulates Decidual Prolactin Expression in Differentiating Human Endometrial Stromal Cells Endocrinology, October 1, 1999; 140(10): 4809 - 4820. [Abstract] [Full Text]

				S. J. Ringstrom, M. Szabo, S. M. Kilen, S. Saberi, K. L. Knox, and N. B. Schwartz The Antiprogestins RU486 and ZK98299 Affect Follicle-Stimulating Hormone Secretion Differentially on Estrus, but not on Proestrus Endocrinology, June 1, 1997; 138(6): 2286 - 2290. [Abstract] [Full Text] [PDF]

				D. Szapary, M. Xu, and S. S. Simons Jr. Induction Properties of a Transiently Transfected Glucocorticoid-responsive Gene Vary with Glucocorticoid Receptor Concentration J. Biol. Chem., November 29, 1996; 271(48): 30576 - 30582. [Abstract] [Full Text] [PDF]

				H. Oshima, D. Szapary, and S. S. Simons Jr. The Factor Binding to the Glucocorticoid Modulatory Element of the Tyrosine Aminotransferase Gene Is a Novel and Ubiquitous Heteromeric Complex J. Biol. Chem., September 15, 1995; 270(37): 21893 - 21901. [Abstract] [Full Text] [PDF]